Yulia Hirschberg

562 total citations
23 papers, 380 citations indexed

About

Yulia Hirschberg is a scholar working on Nutrition and Dietetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yulia Hirschberg has authored 23 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nutrition and Dietetics, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Yulia Hirschberg's work include Renal cell carcinoma treatment (5 papers), Clinical Nutrition and Gastroenterology (4 papers) and Cancer Genomics and Diagnostics (4 papers). Yulia Hirschberg is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Clinical Nutrition and Gastroenterology (4 papers) and Cancer Genomics and Diagnostics (4 papers). Yulia Hirschberg collaborates with scholars based in United States, Switzerland and United Kingdom. Yulia Hirschberg's co-authors include James F. McLeod, James J. Pomposelli, George L. Blackburn, Bruce R. Bistrian, Adel H. Karara, A Pietri, John D. Palombo, Kenneth C. Lasseter, Vigen K. Babayan and Somesh Choudhury and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Circulation Research.

In The Last Decade

Yulia Hirschberg

22 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yulia Hirschberg United States 13 113 104 79 69 52 23 380
Stéphane Eeckhoudt Belgium 17 116 1.0× 129 1.2× 45 0.6× 34 0.5× 58 1.1× 33 572
Catherine E. de Keyser Netherlands 13 103 0.9× 93 0.9× 54 0.7× 72 1.0× 16 0.3× 17 452
L Turecký Slovakia 12 119 1.1× 38 0.4× 55 0.7× 44 0.6× 40 0.8× 36 423
Silvia Natoli Italy 8 129 1.1× 198 1.9× 47 0.6× 41 0.6× 15 0.3× 12 390
K. Lackner Germany 10 48 0.4× 51 0.5× 31 0.4× 70 1.0× 39 0.8× 31 341
G Perani Italy 12 72 0.6× 177 1.7× 113 1.4× 84 1.2× 56 1.1× 34 738
R. C. Day United Kingdom 9 138 1.2× 131 1.3× 97 1.2× 76 1.1× 87 1.7× 12 508
Fausta Micheletta Italy 9 109 1.0× 200 1.9× 50 0.6× 58 0.8× 13 0.3× 14 367
Osamah Hussein Israel 12 48 0.4× 170 1.6× 158 2.0× 65 0.9× 68 1.3× 21 514
Maurizio De Caterina Italy 15 197 1.7× 79 0.8× 36 0.5× 22 0.3× 42 0.8× 30 618

Countries citing papers authored by Yulia Hirschberg

Since Specialization
Citations

This map shows the geographic impact of Yulia Hirschberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulia Hirschberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulia Hirschberg more than expected).

Fields of papers citing papers by Yulia Hirschberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulia Hirschberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulia Hirschberg. The network helps show where Yulia Hirschberg may publish in the future.

Co-authorship network of co-authors of Yulia Hirschberg

This figure shows the co-authorship network connecting the top 25 collaborators of Yulia Hirschberg. A scholar is included among the top collaborators of Yulia Hirschberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulia Hirschberg. Yulia Hirschberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feucht, Martha, Alfons Macaya, Bernd Wilken, et al.. (2022). Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results. Frontiers in Pharmacology. 13. 802334–802334. 9 indexed citations
2.
Powles, T.B., Stéphane Oudard, Viktor Grünwald, et al.. (2020). 718P A phase II study of patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib after previous checkpoint inhibitor treatment. Annals of Oncology. 31. S564–S564. 12 indexed citations
3.
Procopio, Giuseppe, Aristotelis Bamias, Manuela Schmidinger, et al.. (2019). Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 17(3). e526–e533. 8 indexed citations
4.
Schmidinger, Manuela, Aristotelis Bamias, Giuseppe Procopio, et al.. (2019). Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study). The Oncologist. 24(4). 491–497. 22 indexed citations
5.
Procopio, Giuseppe, Aristotelis Bamias, Manuela Schmidinger, et al.. (2018). Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). Annals of Oncology. 29. viii313–viii313. 1 indexed citations
6.
Appel‐Dingemanse, Silke, Yulia Hirschberg, Stuart Osborne, F. Pommier, & James F. McLeod. (2001). Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919). European Journal of Clinical Pharmacology. 56(12). 889–891. 19 indexed citations
7.
Hirschberg, Yulia, Adel H. Karara, A Pietri, & James F. McLeod. (2000). Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.. Diabetes Care. 23(3). 349–353. 51 indexed citations
8.
Choudhury, Somesh, et al.. (2000). Single‐Dose Pharmacokinetics of Nateglinide in Subjects with Hepatic Cirrhosis. The Journal of Clinical Pharmacology. 40(6). 634–640. 38 indexed citations
9.
Hirschberg, Yulia, et al.. (2000). Single-Dose Pharmacokinetics of Nateglinide in Subjects with Hepatic Cirrhosis. The Journal of Clinical Pharmacology. 40(6). 634–640. 11 indexed citations
10.
Fox, Roy, Bernard Faller, Hanspeter Nick, et al.. (1999). In Vitro and In Situ Permeability of a 'Second Generation' Hydroxypyridinone Oral Iron Chelator: Correlation with Physico-Chemical Properties and Oral Activity. Pharmaceutical Research. 16(3). 434–440. 13 indexed citations
11.
Appel‐Dingemanse, Silke, M. Guerret, Yulia Hirschberg, & James F. McLeod. (1999). Single- and multiple-dose pharmacokinetics of SDZ HTF 919 in healthy subjects. Clinical Pharmacology & Therapeutics. 65(2). 128–128. 1 indexed citations
12.
Hirschberg, Yulia, et al.. (1995). Oral absorption of CGS-20625, an insoluble drug, in dogs and man. Journal of Pharmacokinetics and Biopharmaceutics. 23(1). 11–23. 4 indexed citations
13.
Greig, A. S., Yulia Hirschberg, Page A.W. Anderson, et al.. (1994). Molecular basis of cardiac troponin T isoform heterogeneity in rabbit heart.. Circulation Research. 74(1). 41–47. 32 indexed citations
14.
Hirschberg, Yulia, et al.. (1990). Short-term TPN containing n-3 fatty acids ameliorate lactic acidosis induced by endotoxin in guinea pigs. American Journal of Clinical Nutrition. 52(3). 548–552. 19 indexed citations
15.
Hirschberg, Yulia, James J. Pomposelli, Edward A. Mascioli, Bruce R. Bistrian, & George L. Blackburn. (1990). Effect of Tracer and Intravenous Fat Emulsion on the Measurement of Reticuloendothelial System Function. Journal of Parenteral and Enteral Nutrition. 14(5). 463–466. 4 indexed citations
16.
Hirschberg, Yulia, James J. Pomposelli, George L. Blackburn, et al.. (1990). The effects of chronic fish oil feeding in rats on protein catabolism induced by recombinant mediators. Metabolism. 39(4). 397–402. 20 indexed citations
17.
Palombo, John D., James J. Pomposelli, Yulia Hirschberg, George L. Blackburn, & Bruce R. Bistrian. (1989). GLYCOLYTIC SUPPORT OF ADENINE NUCLEOTIDES IN RAT LIVER FLUSH-PRESERVED WITH UW OR COLLINSʼ II. Transplantation. 48(6). 901–905. 32 indexed citations
18.
Mascioli, Edward A., Sheldon Randall, Kathaleen A. Porter, et al.. (1989). Serum fatty acid profiles after intravenous medium chain triglyceride administration. Lipids. 24(9). 793–798. 31 indexed citations
19.
Hirschberg, Yulia, et al.. (1989). Decreased loss of liver nucleotides and energy charge during hypothermic preservation by donor pretreatment with glucose--a preliminary report.. PubMed. 21(1 Pt 2). 1299–300. 2 indexed citations
20.
Palombo, John D., Yulia Hirschberg, James J. Pomposelli, et al.. (1988). Decreased loss of liver adenosine triphosphate during hypothermic preservation in rats pretreated with glucose: Implications for organ donor management. Gastroenterology. 95(4). 1043–1049. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026